Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intermediate-length polyglutamine expansions in ataxin 2 are a risk factor for
amyotrophic lateral sclerosis
(
ALS
). The polyglutamine tract is encoded by a trinucleotide repeat in a coding region of the ataxin 2 gene (ATXN2). Noncoding nucleotide repeat expansions in several genes are also associated with neurodegenerative and neuromuscular diseases. For example, hexanucleotide repeat expansions located in a noncoding region of C9ORF72 are the most common cause of
ALS
. We sought to assess a potential larger role of noncoding nucleotide repeat expansions in
ALS
. We analyzed the nucleotide repeat lengths of 6 genes (ATXN8,
ATXN10
, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with
ALS
and healthy control subjects. We report no association between
ALS
and repeat length in any of these genes, suggesting that variation in the noncoding repetitive regions in these genes does not contribute to
ALS
.
...
PMID:Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis. 2426 18